THE MINISTER OF STATE IN THE MINISTRY OF COMMERCE AND INDUSTRY(SHRI JYOTIRADITYA M. SCINDIA)
(a) to (c) India has decided to engage in a formal Consultation process with European Commission
on this issue. This is a procedure that precedes a formal Dispute in the Dispute Settlement Body
of the World Trade Organization (WTO).
India also raised the matter in a meeting of General Council of the WTO held on 3rd February 2009
and in meetings of TRIPS Council of the WTO held on 3rd March, 2009 and 8th June 2009. India
called upon the EC to urgently review its Regulation 1383/2003 and actions of the national
authorities based on the EC Regulation. India has been pressing that EC Regulations and actions
should be in conformity with the letter and spirit of the TRIPS Agreement, the rules based WTO
system and the Doha Ministerial Declaration on Public Health. India has also being raising the
larger issue of maximalist enforcement of Intellectual Property Rights and their consequential
adverse impact on both access and trade in generic medicines in the meetings of the World Health
Organization. The seizure issue has also been taken up bilaterally with the Netherlands and the
European Commission.